Kyowa Hakko Kirin Co., Ltd.

https://www.kyowa-kirin.co.jp

	Start	2008-10-01 merged
	End	2019-07-01 renamed
	Group	Kyowa Kirin (Group)
	Today	Kyowa Kirin Co., Ltd.
	Predecessor	Kyowa Hakko Kogyo Co., Ltd.
	Successor	Kyowa Kirin Co., Ltd.
	Industry	MAb, human, fully
	Industry 2	pharmaceutical

	Region	Tokyo
	Country	Japan
	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Kyowa Kirin (Group)

[1] Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III"....
[2] GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London....
[3] GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London....
[4] GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]